GramEye

Healthcare ITSeries BIbaraki-shi, Japangrameye.com

Latest round

Series B

Last raised

Nov 2025

Total raised

$6.1M

Investors

7

About GramEye

Based in Osaka, Japan, and founded in 2020, GramEye Inc. develops medical devices that use Gram staining with robotics and deep learning to automate sample handling, process microscopic images, support clinical laboratory operations, and enable consistent analysis across microbiology workflows. In November 2025, GramEye Inc. The company offers medical devices which automate gram staining along with deep learning and robotics. The firm develops artificial intelligence and robotics technology to resolve the problem of drug-resistant bacteria.

Who invested in GramEye

7 investors across 2 rounds

See all investors in GramEye

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Nov 20, 2025

    Amount

    $3.7M

    Investors

    Locked

  2. Series A

    Oct 13, 2023

    Amount

    $2.4M

    Investors

    Locked

Questions about GramEye

Who invested in GramEye?

GramEye has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has GramEye raised?

GramEye has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did GramEye last raise money?

GramEye's most recent round on record is a Series B, in Nov 2025.

What does GramEye do?

Based in Osaka, Japan, and founded in 2020, GramEye Inc.

Where is GramEye headquartered?

GramEye is headquartered in Ibaraki-shi, Japan.

Which VCs invest in companies like GramEye?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back healthcare it companies at GramEye's stage. Their profiles are linked below.

Raising like GramEye? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.